Comprehensive mapping of immune perturbations associated with severe COVID-19-Reference-Cited by-同舟云学术

Comprehensive mapping of immune perturbations associated with severe COVID-19

Published:2020-07-03 Issue:49 Volume:5 Page:
ISSN:2470-9468
Container-title:Science Immunology
language:en
Short-container-title:Sci. Immunol.

Author:

Kuri-Cervantes Leticia¹²^ORCID,Pampena Maria Betina¹²^ORCID,Meng Wenzhao³,Rosenfeld Aaron M.³,Ittner Caroline A. G.⁴,Weisman Ariel R.⁴^ORCID,Agyekum Roseline S.⁴^ORCID,Mathew Divij¹⁵^ORCID,Baxter Amy E.¹⁵^ORCID,Vella Laura A.²⁶^ORCID,Kuthuru Oliva²⁵^ORCID,Apostolidis Sokratis A.²⁵⁷^ORCID,Bershaw Luanne²⁵^ORCID,Dougherty Jeanette²⁵^ORCID,Greenplate Allison R.²⁵^ORCID,Pattekar Ajinkya²⁸^ORCID,Kim Justin²⁵^ORCID,Han Nicholas²⁵^ORCID,Gouma Sigrid¹²^ORCID,Weirick Madison E.¹²^ORCID,Arevalo Claudia P.¹²^ORCID,Bolton Marcus J.¹²^ORCID,Goodwin Eileen C.¹²,Anderson Elizabeth M.¹²^ORCID,Hensley Scott E.¹²^ORCID,Jones Tiffanie K.⁴^ORCID,Mangalmurti Nilam S.²⁴^ORCID,Luning Prak Eline T.³^ORCID,Wherry E. John²⁵⁹^ORCID,Meyer Nuala J.⁴^ORCID,Betts Michael R.¹²^ORCID

Affiliation:

1. Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

2. Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

3. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA 19104, USA.

4. Division of Pulmonary, Allergy and Critical Care, Center for Translational Lung Biology, Lung Biology Institute, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

5. Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

6. Division of Infectious Diseases, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA.

7. Division of Rheumatology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.

8. Division of Gastroenterology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.

9. Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA 19104, USA.

Abstract

Profound plasmablast expansion, innate cell modulation, and T cell activation are defining features of severe COVID-19.

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

Reference100 articles.

1. WHO Novel Coronavirus 2019 Reports (World Health Organization 2020) vol. 2020.

2. Clinical Characteristics of Coronavirus Disease 2019 in China

3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

4. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

5. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Cited by 693 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of plasma nucleocapsid protein in predicting severity and prognosis in severe COVID-19 patients with comorbidities;Clinica Chimica Acta;2025-01

2. Comprehensive mapping of immune perturbations associated with aplastic anemia;Cell Biology and Toxicology;2024-09-13

3. A spatially resolved single-cell lung atlas integrated with clinical and blood signatures distinguishes COVID-19 disease trajectories;Science Translational Medicine;2024-09-11

4. Immunomics in one health: understanding the human, animal, and environmental aspects of COVID-19;Frontiers in Immunology;2024-09-04

5. Data mining antibody sequences for database searching in bottom-up proteomics;ImmunoInformatics;2024-09